Previous evidence indicates that both galectin-1 and galectin-7 inhibit the growth of NB cells [6,7], while galectin-3 is broadly expressed in NB cells to impair the apoptosis-sensitive phenotype induced by MYCN [8]. The gene discussed is LGALS3; the disease is neuroblastoma.